| Literature DB >> 34109159 |
Moupriya Nag1, Dibyajit Lahiri1, Tanmay Sarkar2,3, Sujay Ghosh4, Ankita Dey5, Hisham Atan Edinur6, Siddhartha Pati7,8, Rina Rani Ray5.
Abstract
Bacterial biofilms are responsible for the development of various chronic wound-related and implant-mediated infections and confer protection to the pathogenic bacteria against antimicrobial drugs and host immune responses. Hence, biofilm-mediated chronic infections have created a tremendous burden upon healthcare systems worldwide. The development of biofilms upon the surface of medical implants has resulted in the failure of various implant-based surgeries and therapies. Although different conventional chemical and physical agents are used as antimicrobials, they fail to kill the sessile forms of bacterial pathogens due to the resistance exerted by the exopolysaccharide (EPS) matrices of the biofilm. One of the major techniques used in addressing such a problem is to directly check the biofilm formation by the use of novel antibiofilm materials, local drug delivery, and device-associated surface modifications, but the success of these techniques is still limited. The immense expansion in the field of nanoscience and nanotechnology has resulted in the development of novel nanomaterials as biocidal agents that can be either easily integrated within biomaterials to prevent the colonization of microbial cells or directly approach the pathogen overcoming the biofilm matrix. The antibiofilm efficacies of these nanomaterials are accomplished by the generation of oxidative stresses and through alterations of the genetic expressions. Microorganism-assisted synthesis of nanomaterials paved the path to success in such therapeutic approaches and is found to be more acceptable for its "greener" approach. Metallic nanoparticles functionalized with microbial enzymes, silver-platinum nanohybrids (AgPtNHs), bacterial nanowires, superparamagnetic iron oxide (Fe3O4), and nanoparticles synthesized by both magnetotactic and non-magnetotactic bacteria showed are some of the examples of such agents used to attack the EPS.Entities:
Keywords: antibiofilm; bioprospecting; exopolysaccharide; medical devices; microbial nanomaterials; nanotechnology
Year: 2021 PMID: 34109159 PMCID: PMC8181132 DOI: 10.3389/fchem.2021.690590
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
Properties of bacterial EPS aided synthesized nanoparticles used in nanomaterials.
| Nanoparticle | EPS/component of EPS | Size | Morphology | Reference |
|---|---|---|---|---|
| AgNPs | EPS of | 0.2–10 nm | Spherical or rectangular in shape |
|
| ZnO NPs | EPS of | 100 nm | Hexagonal in its dimensions |
|
| FeO NPs |
| 106 nm | Spherical in shape |
|
| AgNPs |
| 5–50 nm | Oval or rod-like in shape |
|
| Au NPs |
| 10 nms | Spherical in shape |
|
| Ag NPs |
| 35 nm | Spherical in shape |
|
| Ag NPs |
| 10 nm | Spherical or rectangular in shape |
|
| AuNPs and AgNPs | EPS from | 12–20 nm | Ellipsoidal or spherical in shape |
|
| AgNPs | EPS from | 18 nm | Spherical in shape |
|
| AgNPs | EPS from | 10 nm | Hexagonal, triangular, and spherical in shape |
|
| AgNPs | Xanthan gum | 5–40 nm | Spherical in shape |
|
| AuNPs | 15–20 nm | Spherical in shape |
| |
| Pd-NPs | 10 nm | Spherical in shape |
| |
| Pd/FE-NPs | 10–20 nm | Spherical in shape |
| |
| AuNPs | Dextran | 13 nm | Spherical in shape |
|
| Zn-NPs | Curdlan | 58 nm | Spherical in shape |
|
Biogenically synthesized conjugated nanomaterials.
| Type of nanomaterials | Microbial cell associated with the synthesis | Conditions required for synthesis | Characterization of the nanomaterials | Biosynthetic pathways | Reference |
|---|---|---|---|---|---|
| PbS NPs |
| 0.5 mM of lead acetate with 6.4 mM of sodium sulfide along with the growth in potato dextrose agar at a temperature of 30°C for a period of 120 h and 150 rpm | Cubic crystalline structure, 35–100 nm | Extracellular synthesis |
|
| ZnS: Gd NPs and ZnS |
| Fungal cells were grown in potato dextrose agar at 28°C for a period of 115 rpm. Along with the biomass, 3 mM of ZnSO4 was added at 27°C and 200 rpm. For the synthesis of ZnS:Gd NPs, 0.3 mM Gd(NO3)3 was added for a period of 96 h | Nanocrystalline structure, spherical structure, and 12–24 nm. ZnS: Gd NPs—10–18 nm | Extracellular synthesis |
|
| ZnS:Gd nanoparticle 0.3 m | |||||
| Chitosan NPs |
| Filtered biomass of the fungi that was grown in potato dextrose agar for a period of 72 h at 28°C at 180 rpm, followed by the addition | Spherical and amorphous, 98.8 nm | Synthesized extracellularly by enzymes |
|
| AuNPs |
| Fungi were grown for a period of 72 h within potato dextrose broth at 30°C at 200 rpm. The filtered biomass was mixed in Milli Q sterile water and agitated at 30°C for a period of 72 h at 200 rpm. The supernatant was then mixed with HAuCl4 at a concentration of 1 mm at a temperature of 30°C in the dark | Hexagonal and triangular in shape. 25–60 nm | The NPs are synthesized extracellularly. Electrostatic interactions are responsible for the entrapment of ions with the fungal cell wall. The organic reagents that are present within the media are specifically used as reducing agents |
|
| AgNPs |
| The fungi was grown in potato dextrose agar for a period of 5 days, followed by mixing the filtered biomass with 1 mm silver nitrate at 28°C for a period of 120 h in the dark | Face-centered cubic crystal, 5–13 nm | The reductase enzyme helps in the synthesis of the NPs |
|
| AgNPs |
| The fungi were cultured in MGYP media at pH 9 and shaken at 200 rpm for a period of 50°C. This was followed by the addition of the mycelial mass with 1 mM AgNO3, which was shaken at 200 rpm, at a temperature of 50°C for a period of 96 h | Face-centered cubic crystal, spherical, and 5–13 nm | The biomolecules produced by the fungi helps in the extracellular synthesis of NPs |
|
| TeNPs |
| The fungi was grown in Czapek’s medium within a pH range of 7.3 at 30°C for a period of 5 days to which 2 mmol of K2TeO3 was added | Oval and spherical in shape, 60–80 nm |
| |
| CdTe QDs |
| The fungi were grown under anaerobic conditions within Czapek’s medium for a period of 2 days. The cell aliquot stored at 5°C was added with 3 mM CdCl2 along with 0.8 mm Na2TeO3, 1.5 mm CH3SO3H, and 2.6 mm NaBH4, followed by rotation at 500 rpm | Cubic crystal, 2.6–3.0 nm | Extracellular synthesis of NPs |
|
| Magnetosome chains |
| Organisms that were grown micro-anaerobically were mixed with 50 µM of Fe(III)citrate | — | Genetic modification resulting in the enhancement of click beetle luciferase (CBR), thereby increasing the production of NPs |
|
| γ-Fe2O3 magnetosome chains and individual γ-Fe2O3 magnetosomes |
| The organism was grown micro-anaerobically | 150–300 nm | The synthesis of the NPs occurs by the venous proteins that occur by genetic modifications and expression of RGD |
|
| Nanocomposites formed by bacterial nanocellulose with AgNPs AuNPs and CdSe and ZnS quantum dots that remain functionalized in the presence of biotinylated antibodies |
| The synthesis of the NPs was performed within the static | 45 ± 10 nm | Various types of extracellular and intracellular enzymes like glucokinase, phosphoglucomutase, pyrophosphgorylase, UDPG, and cellulose synthase |
|
| Bacterial nanocellulose fibrils |
| Static culture enriched with polysaccharides | 2–100 nms | Various types of extracellular and intracellular enzymes like glucokinase, phosphoglucomutase, pyrophosphorylase, UDPG, and cellulose synthase |
|
| CdTe QDs |
| The bacterial cells were grown in Luria Bertani broth along with 3 mM CdCl2, 0.8 mm Na2TeO3, 6 mM Na3C6H5O7, 26 mM NaBH4, and 8 mM C4H6O4S at 37°C for 24 h at 200 rpm | Cubic structure, size 2–3 nm | Produced extracellularly. Specifically, it is a protein-associated nuclear process |
|
| Ag NPs |
| Bacterial biomass was mixed with 1 mm AgNO3 at a temperature of 37°C | 40–50 nm |
| |
| Ag NPs |
| Bacterial biomass was mixed with 1 mm AgNO3 at a temperature of 37°C | Spherical and crystalline in shape, 2–11 nm | Extracellular synthesis associated with NADH-dependent reductases |
|
| AuNPs and AgNPs |
| Bacterial biomass was mixed with 0.001 M AgNO3 and 0.001 HAuCl4 at a temperature of 37°C | 10–50 nm whereas AuNPs are 0–50 nm | It allows intracellular synthesis of NPs which is an NADH-dependent nitrate reductase for AgNPs and α-NADPH–dependent sulfite reductase for AuNPs |
|
| Au NPs |
| Cell-free supernatant was added with 1 mm HAuCl4 | Spherical in shape, 12 ± 5 nm | It is an extracellular mechanism of synthesis where enzyme-based shuttle-based enzymatic reduction of ionic Au3+ to Au0 occurs |
|
| Se NPs |
| Overnight-grown culture within trypic soy broth added to 1 mm Na2SeO3 at a temperature of 25°C for a period of 24 h | Amorphous and spherical shaped, 100 nm | Se (III) is reduced to Se(0) by the mechanism of intracellular reduction |
|
| Se NPs |
| The bacterial biomass was grown for a period of 120 h. To that, 1 mm Na2SeO3 was added, followed by stirring at 200 rpm | Spherical and crystalline in shape, 10–250 nm | Extracellular synthesis of NPs |
|
| Polycrystalline AgNPs |
| The growth is achieved within F/2 media within filtered sterile brackish water maintained at pH 8.2 at a temperature of 30°C for a period of 16.8 h at a rotation of 120 rpm followed by addition of 2 mm Silver nitrate | 20–25 nm | This involves the process of extracellular synthesis of NPs where fucoxanthin is involved |
|
| Au NPs with biogenic silica | Fossil diatoms | NA | 10–30 µm | NA |
|
| Biogenic silica |
| The growth of the organism was achieved in silicate-rich sea water media at a temperature of 18–20°C for a period of 12:12 light and dark cycles | NA | Natural process of biomineralization |
|
| Streptomycin loaded within biogenic silica |
| NA | 220 µm | Natural process of biomineralization |
|
| AuNPs |
| The organism was grown within Guillard’s Marine Enrichment media at a temperature of 28°C for a period of 15 days under light conditions, followed by the addition of the supernatant with 1 mM HAuCl4 at a rotation of 200 rpm and a temperature of 28–29°C | 5–35 nm | Intracellular synthesis of NPs by means of active compounds that are associated with the cell wall and the cytoplasm |
|
FIGURE 1Action of nanostructures at different points of the biofilm formation event.
FIGURE 2Interaction of NPs with the eDNA present within the biofilm.
Examples of effective application of nanomaterials against device-associated biofilm
| Antibiofilm activity of nanomaterials | Antibiofilm implants on device | Mechanism | Reference |
|---|---|---|---|
| Zinc-associated copper oxide nanocomposite (Zn-CuO) | Contact lenses | Zn-CuO nanocoating being present upon the surface of the lenses prevents the development of biofilm upon their surface |
|
| Silica NPs | Contact lenses | It possesses brush coatings on the polypropylene cases that inhibit the development of biofilm in comparison to the uncoated polypropylene. It also prevents the spreading of microbial colonies upon the surface of the lenses |
|
| Silicone NPs | Used in breast implants | It helps in the reduction of immune responses that are generated by peripheral mononuclear blood cells and can be effectively be used in preventing the development of biofilm |
|
| NPs releasing nitric oxides | Catheters | It plays an effective role in preventing the development of biofilm. It especially prevents the biofilm of |
|
| Ag-Ti nanocomposites | Used within face masks | It prevents the development of biofilm by |
|
| Silver conjugated NPs | Used in prosthetic heart valves | It prevents the development of biofilm by interfering with the sessile colonies |
|
| ZnO NPs along with titanium implants | Used in various types of orthopedic implants | The Ti being present within the ZnO–Ti nanocomposites helps in promoting adhesion of mammalian cells and thereby inhibits the bacterial cell adhesion |
|
| Titania nanostructure coated with AgNPs | Used in oral implants and endodontic filing | It helps in the killing of the planktonic cells and also prevents the development of the biofilm |
|
FIGURE 3Mechanism of NPs bringing about inhibition of biofilm.